SRXH

SRx Health Solutions Inc. · AMEX · Healthcare · USD · 10-K for 2025, filed 2025-12-05

Figures on this page computed 2026-11-08 12:41 UTC

Last close

0.89USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2024, filed 2025-03-31

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- computed
- 10-K for 2024, filed 2025-03-31
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2026-08-13
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2025-05-15
The filing itself
-0.5%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
The filing itself
-12.6%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.29 against 0.52 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

0.26x

1.26x

n/a

0.37x

0.05x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

4 of 5 read

Except where said otherwise: 10-K for 2025, filed 2025-12-05

Sales0.26x
Its own average over 10 years, 25.4M.
Profit1.26x
Its own average over 10 years, -35.6M.
Free cash flown/a
Its own average over 9 years, -8.2M.
Debt0.37x
Its own average over 9 years, 12.0M.
Price0.05x
Its own average over 2 years, 17. Market data, 2026-11-04

Price is furthest from its own average, at 0.05 times.

Sales is 0.26 times its own 10-year average; Profit is 1.26 times its own 10-year average; Debt is 0.37 times its own 9-year average; Price is 0.05 times its own 2-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2025-12-05

Sales against its own 10-year average0.26
Source
filed
Statement
income
Fiscal year
2025
Accession
0001493152-25-026452
Reported in
USD
The filing itself
Profit against its own 10-year average1.26
Source
filed
Statement
income
Fiscal year
2025
Accession
0001493152-25-026452
Reported in
USD
The filing itself
Free cash flow against its own 9-year averagen/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001493152-25-026452
Reported in
USD
The filing itself
Debt against its own 9-year average0.37
Source
filed
Statement
income
Fiscal year
2025
Accession
0001493152-25-026452
Reported in
USD
The filing itself
Price against its own 2-year average0.05Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD